Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-Reported Burden of Chronic Cough in a Managed Care Organization.
Zeiger RS, Schatz M, Hong B, Li Q, Stern JA, Takhar HS, Weaver JP, Bali V, Schelfhout J, Chen W. Zeiger RS, et al. Among authors: schelfhout j. J Allergy Clin Immunol Pract. 2021 Apr;9(4):1624-1637.e10. doi: 10.1016/j.jaip.2020.11.018. Epub 2020 Nov 20. J Allergy Clin Immunol Pract. 2021. PMID: 33227523
Prevalence and Burden of Chronic Cough in the United States.
Meltzer EO, Zeiger RS, Dicpinigaitis P, Bernstein JA, Oppenheimer JJ, Way NA, Li VW, Boggs R, Doane MJ, Urdaneta E, Weaver JP, Schelfhout J, Fonseca E. Meltzer EO, et al. Among authors: schelfhout j. J Allergy Clin Immunol Pract. 2021 Nov;9(11):4037-4044.e2. doi: 10.1016/j.jaip.2021.07.022. Epub 2021 Jul 29. J Allergy Clin Immunol Pract. 2021. PMID: 34333189
Management of Chronic Cough in Adult Primary Care: A Qualitative Study.
Gowan TM, Huffman M, Weiner M, Talib TL, Schelfhout J, Weaver J, Griffith A, Doshi I, Dexter P, Bali V. Gowan TM, et al. Among authors: schelfhout j. Lung. 2021 Oct;199(5):563-568. doi: 10.1007/s00408-021-00478-y. Epub 2021 Sep 30. Lung. 2021. PMID: 34591158 Free PMC article. No abstract available.
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.
McGarvey LP, Birring SS, Morice AH, Dicpinigaitis PV, Pavord ID, Schelfhout J, Nguyen AM, Li Q, Tzontcheva A, Iskold B, Green SA, Rosa C, Muccino DR, Smith JA; COUGH-1 and COUGH-2 Investigators. McGarvey LP, et al. Among authors: schelfhout j. Lancet. 2022 Mar 5;399(10328):909-923. doi: 10.1016/S0140-6736(21)02348-5. Lancet. 2022. PMID: 35248186 Clinical Trial.
49 results